Hajime Onoe

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana et al. · The Lancet · 2024 · 113 citations

Health Professions, Ophthalmology, Pharmacotherapy +10

Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan

Ryo Mukai, Keiko Kataoka, Koji Tanaka et al. · Scientific Reports · 2023 · 84 citations · Full text

Medicine, Pharmacotherapy, Clinical Vision Science +15

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration

Keiko Kataoka, Kanako Itagaki, Nozumu Hashiya et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2023 · 68 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation.

Kyo Yamasu, Hajime Onoe, Go Soma et al. · PubMed · 1989 · 36 citations

Life Sciences, Developmental Biology, Immunology +13

Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study

Tamaki Tamashiro, Koji Tanaka, Kanako Itagaki et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2022 · 33 citations

Medicine, Ophthalmology, Pharmacotherapy +16